Press release
United States Sexually Transmitted Diseases (STD) Diagnostics Market 2025 | Growth Drivers, Key Players & Investment Opportunities
Sexually Transmitted Diseases (STD) Diagnostics Market
The Global Sexually Transmitted Diseases (STD) diagnostics market reached US$ 10.6 billion in 2024 and is expected to reach US$ 19.4 billion by 2033, growing at a CAGR of 7.1% during the forecast period 2025-2033, according to DataM Intelligence report.
Key Development:
United States
✅ August 2025: The Gates Foundation committed $2.5 billion through 2030 to accelerate R&D in women's health, including innovations in STI diagnostics, particularly for low- and middle-income countries.
✅ July 2025: Visby Medical announced the launch of an FDA-authorized at-home STI test for women, delivering lab-accurate results in 30 minutes via a smartphone app.
✅ June 2025: Sherlock Bio initiated trials for an over-the-counter rapid STI test, aiming for a mid-2025 launch, enabling users to collect samples at home and receive results within 30 minutes.
Japan
✅ 2025: The WHO's prequalification process expanded to include STI diagnostics, promoting access to quality-assured tests for chlamydia, gonorrhea, and trichomoniasis.
✅ 2025: A study developed a new rapid simultaneous molecular assay for STI detection, enabling quick and accurate diagnosis, including drug resistance mutations.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/sexually-transmitted-diseases-diagnostics-market?sb
Recent Mergers and Acquisitions:
United States
✅ September 2025: Private equity firms Blackstone and TPG renewed interest in acquiring Hologic, a medical diagnostics company focusing on women's health, in what could become a major healthcare take-private deal in 2025.
✅ July 2025: Waters Corporation announced a $17.5 billion merger with Becton Dickinson's Biosciences & Diagnostic Solutions division, aiming to enhance capabilities in multiplex diagnostics and bioanalytical characterization.
✅ May 2025: Hologic received a $16.7 billion take-private offer from TPG and Blackstone, which was later rejected, highlighting ongoing consolidation in the diagnostics sector.
Key Players:
=> Abbott Laboratories, Becton, Dickinson, and Company, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Hologic, Inc., QIAGEN N.V., Diasorin S.p.A., Seegene Inc., Bosch Healthcare Solutions GmbH and among others.
Growth Forecast Projected:
The Global Sexually Transmitted Diseases (STD) diagnostics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Sexually Transmitted Diseases (STD) diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=sexually-transmitted-diseases-diagnostics-market
Key Segments:
➥ By Product Type: Instruments, Consumables, Software
➥ By Disease Type: Chlamydia, Genital Herpes, Gonorrhea, Hepatitis B, HIV/AIDS, Human Papillomavirus (HPV), Syphilis, Others
➥ By Diagnostic Test Type: Molecular Tests, Serologic Tests, Point-of-Care (PoC) Tests, Others
➥ By End-User: Hospitals, Specialty Clinics, Diagnostic Laboratories, Homecare Settings, Others
Regional Analysis for Sexually Transmitted Diseases (STD) diagnostics Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Sexually Transmitted Diseases (STD) diagnostics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Sexually Transmitted Diseases (STD) diagnostics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/sexually-transmitted-diseases-diagnostics-market?sb
FAQ
What is the current size of the Sexually Transmitted Diseases (STD) diagnostics Market?
A: In 2024, the Sexually Transmitted Diseases (STD) diagnostics Market was valued at US$ 10.6 billion , reflecting its strong industry presence.
Q2: How large is the Sexually Transmitted Diseases (STD) diagnostics Market expected to be by 2033?
A: By 2033, industry forecasts suggest the Sexually Transmitted Diseases (STD) diagnostics Market will grow to around US$ 19.4 billion , demonstrating significant expansion.
Q3: What is the growth rate of the Sexually Transmitted Diseases (STD) diagnostics Market?
A: The market is projected to expand at a compound annual growth rate (CAGR) of 7.1% during the forecast period from 2025 to 2033.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb
Contact Us
-
Company
Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Sexually Transmitted Diseases (STD) Diagnostics Market 2025 | Growth Drivers, Key Players & Investment Opportunities here
News-ID: 4206986 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States H3N2 Drug Industry Surge: How Pharma Companies Are Tackling Influe …
DataM Intelligence unveils its latest report on the "H3N2 Infection Drugs Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies…
Smart Thermometers Market 2025 | Industry Developments, Future Growth, Share & I …
The Smart Thermometers Market reached US$ 766.27 million in 2024 and is projected to reach US$ 1,990.39 million by 2033, growing at a CAGR of 11.3% during the forecast period 2025-2033.
DataM Intelligence unveils its latest report on the "Smart Thermometers Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging…
Remote Browser Isolation Market 2025 | Industry Developments, Future Growth, Sha …
The Remote Browser Isolation Market was valued at US$ 0.59 billion in 2024 and is anticipated to reach US$ 5.35 billion by 2032, expanding at a CAGR of 31.75% during the forecast period 2025-2032.
DataM Intelligence unveils its latest report on the "Remote Browser Isolation Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume,…
United States Fig Fruit Extracts Industry Poised for Growth with Rising Health T …
DataM Intelligence unveils its latest report on the "Fig Fruit Extracts Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
